Florentina M.E. Pinckaers

Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

Susanne G. H. Olthuis, F.A.V. Pirson, Florentina M.E. Pinckaers et al. · The Lancet · 2023 · 237 citations · Full text

Medicine, Neurology, Surgery +16

Risk factors predisposing to psychotic symptoms during levetiracetam therapy: A retrospective study

Florentina M.E. Pinckaers, M. Boon, Marian Majoie · Epilepsy & Behavior · 2019 · 23 citations · Full text

Medicine, Pharmacology, Psychiatry +16

Collateral-based selection for endovascular treatment of acute ischaemic stroke in the late window (MR CLEAN-LATE): 2-year follow-up of a phase 3, multicentre, open-label, randomised controlled trial in the Netherlands

Ilse Huijberts, Florentina M.E. Pinckaers, Susanne G. H. Olthuis et al. · The Lancet Neurology · 2024 · 22 citations · Full text

Medicine, Neurology, Surgery +17

Evidence for interaction between genetic liability and childhood trauma in the development of psychotic symptoms

Florentina M.E. Pinckaers, Iris Leah Marije Rotee, Chinyere Vicky Nwosu et al. · Social Psychiatry and Psychiatric Epidemiology · 2019 · 14 citations · Full text

Medicine, Psychiatry, Psychology +17

Cost and Utility Estimates per Modified Rankin Scale Score up to 2 Years Post Stroke: Data to Inform Economic Evaluations From a Societal Perspective

Florentina M.E. Pinckaers, Janneke P.C. Grutters, Ilse Huijberts et al. · Value in Health · 2024 · 13 citations · Full text

Pharmacy, Pharmacoeconomics, Cost-utility Analysis +16